Tuesday, October 28, 2025
- 10:30AM-12:30PM
- 
					Abstract Number: 2244
 Bone Mineral Density Trajectories and Fracture Risk in Rheumatoid Arthritis: A 7-Year Longitudinal Analysis Using Group-Based Trajectory Modeling(2227–2264) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III- 10:30AM-12:30PM
- 
					Abstract Number: 1840
 Breathomics in Systemic Lupus Erythematosus: uncovering non-invasive markers of disease activity(1830–1854) Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster- 10:30AM-12:30PM
- 
					Abstract Number: 1770
 Brepocitinib Inhibits Key Pathogenic Cytokine Signaling in Dermatomyositis Patients(1770–1779) Cytokines & Cell Trafficking Poster- 10:30AM-12:30PM
- 
					Abstract Number: 1982
 Bridging the Gap in Underserved Care: A Quality Improvement Initiative to Increase Pneumococcal Vaccination Rates in Immunocompromised Rheumatology Patients(1972–1989) Measures & Measurement of Healthcare Quality Poster II- 10:30AM-12:30PM
- 
					Abstract Number: 2169
 Bridging the Gap: A National Needs Assessment of Rheumatology Fellowship Training in Adolescent and Young Adult Care(2159–2194) Professional Education Poster- 10:30AM-12:30PM
- 
					Abstract Number: 2156
 Bridging the Gap: Juvenile Spondyloarthritis (JSpA) vs. Chronic Non-Bacterial Osteomyelitis (CNO)(2124–2158) Pediatric Rheumatology – Clinical Poster III- 10:30AM-12:30PM
- 
					Abstract Number: 2183
 Bridging the Musculoskeletal Ultrasound Training Gap: Analysis of Confidence, Competency, and Clinical Readiness(2159–2194) Professional Education Poster- 10:30AM-12:30PM
- 
					Abstract Number: 2530
 Broad Screening of Inflammation-Associated Proteins Identifies Serum CCL19 and CCL2 as Versatile Biomarkers of Disease Activity in IgG4-Related Disease(2524–2546) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III- 10:30AM-12:30PM
- 
					Abstract Number: 2528
 Broad Screening of the Human Proteome Identifies a Cassette of Six Autoantigens that Distinguishes IgG4-Related Disease(2524–2546) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III- 10:30AM-12:30PM
- 
					Abstract Number: 2437
 Bupropion for Lupus-Induced Fatigue Treatment (B-LIFT): A Retrospective Analysis(2437–2469) Systemic Lupus Erythematosus – Treatment Poster III- 10:30AM-12:30PM
- 
					Abstract Number: 1930
 Can a Multinational Awareness Campaign Improve Referral Rates and Reduce Diagnostic Delays in Patients with Chronic Inflammatory Rheumatic Diseases? The Impact of a Prospective Interventional Study(1914–1935) Health Services Research Poster III- 10:30AM-12:30PM
- 
					Abstract Number: 2021
 Can Colchicine Be a Therapeutic Option for Patients with Ankylosing Spondylitis?(2015–2051) Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
- 
					Abstract Number: 2000
 Can Uric Acid Protect Joints? Lower Incidence of Large Joint Replacements Among Individuals with Higher SUA(1990–2014) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II- 10:30AM-12:30PM
- 
					Abstract Number: 1900
 Capturing Patient Cohorts: A Temporal Arteritis Classifier
 
 
 
 
 
 
 
 
 
 
 
 
 
